A previous study revealed that activation of SRC can protect cancer cells from ferroptosis by suppressing the expression of ACSL4, an enzyme that enriches membranes with PUFAs and is required for ferroptosis, revealing the inhibitory role of SRC in ferroptosis (Brown et al., 2017). The gene discussed is ACSL4; the disease is cancer.